Atlas Trials

Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery

Clinical trial NCT00410553 · COMPLETED

Trial details

NCT number
NCT00410553
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Adult Solid NeoplasmRecurrent Ovarian CarcinomaRecurrent Uterine Corpus CarcinomaStage III Ovarian Cancer AJCC v6 and v7Stage III Uterine Corpus Cancer AJCC v7Stage IV Ovarian Cancer AJCC v6 and v7Stage IV Uterine Corpus Cancer AJCC v7
Start date
2006-11-14
Primary completion
2012-10-24
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.